Chemistry:Nimorazole

Nimorazole
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	P01AB06 (WHO) QP51AA06 (WHO);
Identifiers
	IUPAC name 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]morpholine;
CAS Number	6506-37-2;
PubChem CID	23009;
ChemSpider	21533;
UNII	469ULX0H4G;
KEGG	D07352 ;
Chemical and physical data
Formula	C9H14N4O3
Molar mass	226.236 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1COCCN1CCN2C=NC=C2[N+](=O)[O-];
	InChI InChI=1S/C9H14N4O3/c14-13(15)9-7-10-8-12(9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2; Key:MDJFHRLTPRPZLY-UHFFFAOYSA-N;
	(verify)

Short description: Chemical compound

Nimorazole (INN) is a nitroimidazole anti-infective.^[1] It is also being investigated for the treatment of head and neck cancer.^[2]^[3]

References

↑ "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases 51 (4): 281–4. August 1975. doi:10.1136/sti.51.4.281. PMID 1098732.
↑ "Treatment of head and neck cancer with CHART and nimorazole: phase II study". Radiotherapy and Oncology 66 (1): 65–70. January 2003. doi:10.1016/S0167-8140(02)00284-0. PMID 12559522.
↑ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Nimorazole. Read more